Skip to main content

Table 4 Reviews on missing data and ITT in the BMJ, JAMA, NEJM and the Lancet 1

From: Handling missing data in RCTs; a review of the top medical journals

Study

Timing

Study inclusion criteria

Number of trials included

Number (%) of papers with missing data2

Number (%) of papers with more than 10% missing data2

Missing data approaches in primary analysis

Number (%)3

Number (%) of papers reporting sensitivity analysis3

Number (%) of papers reporting ITT4

Hollis et al., 1999 [2]

1997

All RCTs

249

89/119 (75)

29/119 (24)

Complete case

44 (49)

1 (1)

119/249 (48)

Simple imputation

15 (17)

Multiple imputation

0

Model based

29 (33)

Unclear

1 (1)

Wood et al., 2004 [22]

July-Dec, 2001

All RCTs with non-survival outcomes

71

63/71 (89)

36/71 (51)

Complete case

41 (65)

13 (21)

26/63 (41)

Simple imputation

14 (22)

Multiple imputation

1 (2)

Model based

5 (8)

Unclear

2 (3)

Gravel et al., 2007 [1]

2002

Sample of RCTs1

403

152/249 (61)

52/249 (21)

Complete case

89 (59)

Not reported

249/403 (62)

Simple imputation

32 (21)

201/283 (71)5

Multiple imputation

1 (1)

Model based6

0

Unclear6

30 (20)

Fielding et al., 2008 [21]

2005-2006

Random sample of RCTs with Quality of life outcomes

61

55/61 (90)

22/61 (36)

Complete case

30 (55)

6 (11)

Not reported

Simple imputation

11 (20)

Multiple imputation

1 (2)

Model based

9 (16)

Unclear

4 (7)

Bell et al., (current study)

July-Dec, 2013

All RCTS with non-survival outcomes

77

73/77 (95)

36/77 (47)

Complete case

33 (45)

27 (37)

62/73 (85)

Simple imputation

20 (27)

Multiple imputation

6 (8)

Model based

14 (19)

  1. 1Gravel et al. reported on 10 journals, including the BMJ, JAMA, NEJM and the Lancet.
  2. 2Denominator is the number of trials included except for Hollis et al. and Gravel et al., where denominators are the number of papers reporting ITT.
  3. 3Denominator is the number of papers with missing data.
  4. 4Denominator is the number of papers with missing data except for Hollis et al. and Gravel et al. where denominators are the number of trials included in the review.
  5. 5Sub-analysis of RCTs from the four journals (BMJ, JAMA, NEJM and the Lancet) out of the 10 journals included in Gravel’s review.
  6. 6Three reported as “other” might be model based (added to 27 marked “unclear”).